Amgen and Wyeth Pharmaceuticals, a division of Wyeth announced that Enbrel (etanercept) (25 mg twice weekly) is the first biologic to be approved by the U.S. Food and Drug Administration (FDA) to ...
SAN FRANCISCO (MarketWatch) - Amgen Inc. was ordered by regulators to pull a television ad that overstated the effectiveness of its Enbrel psoriasis treatment. In a letter to Amgen AMGN Chief ...
SAN FRANCISCO -- Immunex Corp. will tell doctors its popular rheumatoid arthritis drug Enbrel can treat other joint and spinal disorders, part of a strategy to expand the market for Enbrel and keep it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results